NDRI joins call urging U.S. House and Senate Appropriations Committee Leadership to increase funding for the National Institutes of Health (NIH) and to preserve provisions which prevent the Department of Health and Human Services (HHS) from making abrupt changes to indirect reimbursement rates.  The letter has been signed by more than 600 organizations including national and local patient organizations, academic institutions, independent research organizations, scientific and medical societies.

“The changes proposed by the Administration would cause immediate and irreparable harm to US world leadership in biomedical research ” said Bill Leinweber, President and CEO of NDRI.